Puerarin can protect against hepatic steatosis, inflammation, and fibrosis, and improve NAFLD by regulating PARP-1/PI3K/AKT signaling pathway in male C57BL/6J mice (Wang S. et al., 2016). The gene discussed is PARP1; the disease is Hepatic steatosis.